Cargando…
Novel Chemically Modified Curcumin (CMC) Derivatives Inhibit Tyrosinase Activity and Melanin Synthesis in B16F10 Mouse Melanoma Cells
Skin hyperpigmentation disorders arise due to excessive production of the macromolecular pigment melanin catalyzed by the enzyme tyrosinase. Recently, the therapeutic use of curcumin for inhibiting tyrosinase activity and production of melanin have been recognized, but poor stability and solubility...
Autores principales: | Goenka, Shilpi, Johnson, Francis, Simon, Sanford R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145596/ https://www.ncbi.nlm.nih.gov/pubmed/33946371 http://dx.doi.org/10.3390/biom11050674 |
Ejemplares similares
-
Novel Chemically Modified Curcumin (CMC) Analogs Exhibit Anti-Melanogenic Activity in Primary Human Melanocytes
por: Goenka, Shilpi, et al.
Publicado: (2021) -
Novel Hydrogenated Derivatives of Chemically Modified Curcumin CMC2.24 Are Potent Inhibitors of Melanogenesis in an In Vitro Model: Influence of Degree of Hydrogenation
por: Goenka, Shilpi
Publicado: (2023) -
Camellia japonica Essential Oil Inhibits α-MSH-Induced Melanin Production and Tyrosinase Activity in B16F10 Melanoma Cells
por: Ha, Si Young, et al.
Publicado: (2021) -
Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo
por: Đorđić, Marija, et al.
Publicado: (2012) -
Nanoemulsified adlay bran oil reduces tyrosinase activity and melanin synthesis in B16F10 cells and zebrafish
por: Ting, Yuwen, et al.
Publicado: (2019)